Cargando…

Lower mortality risk in APOE4 carriers with normal cognitive ageing

Abnormal cognitive ageing, including dementia, poses serious challenges to health and social systems in ageing populations. As such, characterizing factors associated with abnormal cognitive ageing and developing needed preventive measures are of great importance. The ε4 allele of the Apolipoprotein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pirraglia, Elizabeth, Glodzik, Lidia, Shao, Yongzhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497512/ https://www.ncbi.nlm.nih.gov/pubmed/37699966 http://dx.doi.org/10.1038/s41598-023-41078-5

Ejemplares similares

Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid
por: Lim, Yen Ying, et al.
Publicado: (2021)

FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease
por: Murray, John, et al.
Publicado: (2014)

Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects
por: Glodzik, Lidia, et al.
Publicado: (2016)

Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study
por: Mosconi, Lisa, et al.
Publicado: (2014)

A Triple Network Connectivity Study of Large-Scale Brain Systems in Cognitively Normal APOE4 Carriers
por: Wu, Xia, et al.
Publicado: (2016)

Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers
por: Sun, Yu, et al.
Publicado: (2019)

Amyloid deposition and ApoE4 carriers in idiopathic normal pressure hydrocephalus
por: Bundo, Masahiko, et al.
Publicado: (2015)

Higher Brain Perfusion May Not Support Memory Functions in Cognitively Normal Carriers of the ApoE ε4 Allele Compared to Non-Carriers
por: Zlatar, Zvinka Z., et al.
Publicado: (2016)

Interaction between KLOTHO-VS Heterozygosity and APOE ε4 Allele Predicts Rate of Cognitive Decline in Late-Onset Alzheimer’s Disease
por: Chen, Xi Richard, et al.
Publicado: (2023)

Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition
por: Wesenhagen, Kirsten E.J., et al.
Publicado: (2022)

THE COMPARISON OF DUAL TASK TIME AMONG APOE CARRIERS AGAINST NON-APOE CARRIERS IN AGING ADULTS
por: Diehl, Cody, et al.
Publicado: (2022)

Increased hippocampal activation in ApoE-4 carriers and non-carriers with amnestic mild cognitive impairment
por: Tran, Tammy T., et al.
Publicado: (2016)

Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of APOE4 Homozygotes and Non-APOE4 Carriers with Mild Cognitive Impairment versus Subjective Cognitive Decline
por: den Hoedt, Sandra, et al.
Publicado: (2023)

White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes
por: Operto, Grégory, et al.
Publicado: (2018)

Accelerated Cell Aging in Female APOE-ε4 Carriers: Implications for Hormone Therapy Use
por: Jacobs, Emily G., et al.
Publicado: (2013)

Structural brain volume differences between cognitively intact ApoE4 carriers and non-carriers across the lifespan
por: Piers, Ryan J.
Publicado: (2018)

Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife
por: Zokaei, Nahid, et al.
Publicado: (2017)

Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score
por: Ebenau, Jarith L., et al.
Publicado: (2021)

The Effects of rs405509 on APOEε4 Non-carriers in Non-demented Aging
por: Wu, Dongpeng, et al.
Publicado: (2021)

Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults
por: Kang, Dong Woo, et al.
Publicado: (2022)

Sex and APOE ɛ4 modify the effect of cardiovascular risk on tau in cognitively normal older adults
por: Tsiknia, Amaryllis A., et al.
Publicado: (2022)

Evidence of cerebral hemodynamic dysregulation in middle-aged APOE ε4 carriers: The PREVENT-Dementia study
por: Dounavi, Maria-Eleni, et al.
Publicado: (2021)

Gray Matter Densities in Limbic Areas and APOE4 Independently Predict Cognitive Decline in Normal Brain Aging
por: Herrmann, François R., et al.
Publicado: (2019)

The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers
por: Martínez, Manuel Fernández, et al.
Publicado: (2009)

Corrigendum: The Effects of rs405509 on APOEε4 Non-carriers in Non-demented Aging
por: Wu, Dongpeng, et al.
Publicado: (2022)

mTOR: Alzheimer's disease prevention for APOE4 carriers
por: Lin, Ai-Ling, et al.
Publicado: (2016)

Impaired memory-guided attention in asymptomatic APOE4 carriers
por: Zimmermann, Jacqueline, et al.
Publicado: (2019)

Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers
por: Norwitz, Nicholas G., et al.
Publicado: (2021)

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
por: Löwe, Luise Christine, et al.
Publicado: (2016)

Influence of APOE Genotype on Mortality and Cognitive Impairment
por: Robinson, Andrew C., et al.
Publicado: (2020)

Segmented Linear Mixed Model Analysis Reveals Association of the APOE ɛ4 Allele with Faster Rate of Alzheimer’s Disease Dementia Progression
por: Chen, X. Richard, et al.
Publicado: (2021)

Interactive effect of age and APOE-ε4 allele load on white matter myelin content in cognitively normal middle-aged subjects
por: Operto, Grégory, et al.
Publicado: (2019)

Alterations in dorsal and ventral posterior cingulate connectivity in APOE ε4 carriers at risk of Alzheimer's disease
por: Kerestes, Rebecca, et al.
Publicado: (2015)

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease
por: Li, Yi, et al.
Publicado: (2008)

Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status
por: Wu, Che‐Yuan, et al.
Publicado: (2020)

Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers
por: Tao, Qiushan, et al.
Publicado: (2018)

APOE4 Status and Cognitive Function in Middle-aged and Elderly People
por: Pavel, N.A., et al.
Publicado: (2023)

SPON1 Is Associated with Amyloid-β and APOE ε4-Related Cognitive Decline in Cognitively Normal Adults
por: Fernandez, Shane, et al.
Publicado: (2021)

Impact of APOE ε4 Carrier Status on Associations Between Subthreshold, Positive Amyloid-β Deposition, Brain Function, and Cognitive Performance in Cognitively Normal Older Adults: A Prospective Study
por: Kang, Dong Woo, et al.
Publicado: (2022)

Functional Brain Network Connectivity Patterns Associated With Normal Cognition at Old-Age, Local β-amyloid, Tau, and APOE4
por: Quevenco, Frances C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9auh9vlmvagblpg83hjnhuig9p